Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2025)
Rapid Micro Biosystems (RPID) reported Asset Writedowns and Impairment of $695000.0 for Q4 2025, up 892.86% on a YoY basis from $70000.0 in Q4 2024, and up 62.0% sequentially from $429000.0 in Q3 2025.
Rapid Micro Biosystems (RPID) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Rapid Micro Biosystems (RPID) has 5 years of Asset Writedowns and Impairment data on file, last reported at $695000.0 in Q4 2025.
- For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 892.86% year-over-year to $695000.0; the trailing twelve-month figure through Mar 2026 stood at $908000.0 (up 175.15% YoY), and the FY2025 full-year result was $1.1 million, up 1103.16% from the prior year.
- Asset Writedowns and Impairment rose to $695000.0 in Q4 2025, from $429000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $695000.0 in Q4 2025 to a low of -$216000.0 in Q2 2025.
- A 5-year average of $135000.0 and a median of $59500.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Peak annual rise in Asset Writedowns and Impairment reached 2733.33% in 2022, while the deepest fall reached 568.75% in 2022.
- Tracing RPID's Asset Writedowns and Impairment over 5 years: stood at $16000.0 in 2021, then surged by 568.75% to $107000.0 in 2022, then slumped by 68.22% to $34000.0 in 2023, then jumped by 105.88% to $70000.0 in 2024, then jumped by 892.86% to $695000.0 in 2025.
- Business Quant data shows RPID's Asset Writedowns and Impairment at $695000.0 in Q4 2025, $429000.0 in Q3 2025, and -$216000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 695,000.00 |
| Dec 31, 2025 | 695,000.00 |
| Sep 30, 2025 | 429,000.00 |
| Sep 30, 2025 | 429,000.00 |
| Jun 30, 2025 | -216,000.00 |
| Jun 30, 2025 | -216,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Sep 30, 2022 | 170,000.00 |
| Jun 30, 2022 | 49,000.00 |
| Jun 30, 2022 | 49,000.00 |